Ikarian Capital, LLC - Significant Ownership

Signature - Title
/s/ Neil Shahrestani - Neil Shahrestani, Sole Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ikarian Capital, LLC.

Notify me when Ikarian Capital, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ikarian Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLTO Galecto, Inc. Common Stock, $0.00001 par value per share 21.5% 286K Ikarian Capital, LLC Nov 30, 2025
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 15.5% $6.47M 968K 0% Ikarian Capital, LLC Nov 30, 2025
SPRB Spruce Biosciences Inc. Common Stock, par value $0.0001 per share 11.4% $1.06M 121K 0% Ikarian Capital, LLC Oct 31, 2025
TRAW Traws Pharma, Inc. Common stock, par value $.01 per share 9.99% $902K $299K 590K +49.5% Ikarian Capital, LLC Mar 31, 2025
GRTX Galera Therapeutics, Inc. Common Stock, $0.001 par value per share 9.99% $377K 7.54M Ikarian Capital, LLC Dec 31, 2024
CHRO Channel Therapeutics Corp Common Stock, par value $0.0001 per share 7.3% $564K 441K Ikarian Capital, LLC Dec 31, 2024
ATXI Avenue Therapeutics, Inc. Common Stock 6.8% $35K 140K Ikarian Capital, LLC Dec 31, 2024
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 6.1% $5.22M 186K Ikarian Capital, LLC Sep 30, 2025
ACOG Alpha Cognition Inc. Common Shares, no par value 6% $4.99M 968K Ikarian Capital, LLC Dec 31, 2024
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 4.99% $6.52M $89.1K 618K +1.39% Ikarian Capital, LLC Jun 30, 2025
IBIO IBIO, Inc. Common Stock 4.99% $947K 1.15M Ikarian Capital, LLC Sep 30, 2025
CPIX Cumberland Pharmaceuticals Inc. Common Stock, no par value 4.9% $3.55M 731K Ikarian Capital, LLC Mar 31, 2025
RLMD Relmada Therapeutics, Inc. Common Stock, par value $0.001 par value per share 4.8% $7.12M 3.54M Ikarian Capital, LLC Sep 30, 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value 3.8% $9.05M -$6.1M 712K -40.3% Ikarian Capital, LLC Sep 30, 2025
AEMD Aethlon Medical, Inc. Common Stock, $0.001 par value per share 2% $5.69K -$449K 15.4K -98.8% Ikarian Capital, LLC Sep 30, 2025

Schedules 13D/G Reported by Ikarian Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.